Intra-Seasonal Initiation of the SQ-Standardised Grass Allergy Immunotherapy Tablet Routinely Applied by Allergy Specialists and General Practitioners with Experience in Treatment of Allergy: A Non-Interventional Observational Study

INTRODUCTION: Intra-seasonal start of treatment with the SQ(®) grass sublingual immunotherapy (SLIT) tablet (GRAZAX(®), ALK, Denmark) has been previously demonstrated to be well-tolerated. The objective of our study was to investigate the tolerability of intra-seasonal start of treatment comparing p...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwab, Jan-Alexander, Wolf, Hendrik, Schnitker, Jörg, Wüstenberg, Eike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare Communications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964259/
https://www.ncbi.nlm.nih.gov/pubmed/32026241
http://dx.doi.org/10.1007/s41030-018-0050-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964259/
https://www.ncbi.nlm.nih.gov/pubmed/32026241
http://dx.doi.org/10.1007/s41030-018-0050-1

Ejemplares similares